These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8600607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y, Marc-Aurèle J, Bielmann P, Alaupovic P, Cartier P, Bichet D, Thibault G, Lupien PJ.
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T, Lithell H, Selinus I, Berne C.
    BMJ; 1989 Apr 29; 298(6681):1152-7. PubMed ID: 2500169
    [Abstract] [Full Text] [Related]

  • 9. [Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].
    Witchitz S, Provendier O, Arsenescu I.
    Presse Med; 1996 Dec 21; 25(40):2013-6. PubMed ID: 9082374
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug 21; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 13. Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters.
    Lithell HO, Pollare T, Berne C.
    J Cardiovasc Pharmacol; 1990 Aug 21; 15 Suppl 5():S46-52. PubMed ID: 1694931
    [Abstract] [Full Text] [Related]

  • 14. Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Shichiri M, Sunaga T, Mashiba H, Tanaka N, Nonaka K, Arakawa K.
    Int J Clin Pharmacol Ther; 1995 Jun 21; 33(6):366-70. PubMed ID: 7582390
    [Abstract] [Full Text] [Related]

  • 15. Long-term metabolic effects of antihypertensive drugs.
    Lind L, Pollare T, Berne C, Lithell H.
    Am Heart J; 1994 Dec 21; 128(6 Pt 1):1177-83. PubMed ID: 7985599
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.
    Hauf-Zachariou U, Widmann L, Zülsdorf B, Hennig M, Lang PD.
    Eur J Clin Pharmacol; 1993 Dec 21; 45(2):95-100. PubMed ID: 8223847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.
    Pollare T, Lithell H, Mörlin C, Präntare H, Hvarfner A, Ljunghall S.
    J Hypertens; 1989 Jul 21; 7(7):551-9. PubMed ID: 2668407
    [Abstract] [Full Text] [Related]

  • 19. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Jul 21; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 20. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct 21; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.